Ira Sohn
Since 1996, the world-renowned Sohn Investment Conference has been the premier investment forum, bringing together the world's savviest investors to share fresh insights and strategies in support of pediatric cancer research and treatment.
Wall Street's best and brightest investors participate in this unique, 'must attend' event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset allocators and private investors. Most speakers manage large proprietary investment portfolios that have outperformed the market for many years and do not share their insights in any public forum, but they volunteer their time to the Conference for the benefit of the Foundation. All contributions support the Foundation's mission to support pediatric research and care.
View Older Stories View More Recent Stories
-
Astrana Health appoints George Christides as interim medical director
-
Form 4 CADENCE DESIGN SYSTEMS For: May 07 Filed by: SOHN YOUNG
-
Form 4 CADENCE DESIGN SYSTEMS For: May 06 Filed by: SOHN YOUNG
-
Form 13F-HR B. Metzler seel. Sohn & For: Mar 31
-
Form 4 TON Strategy Co For: Apr 29 Filed by: Sohn Evan
-
Form 4 Altimmune, Inc. For: May 01 Filed by: Sohn Catherine A.
-
Form 4 Z Squared Inc. For: Apr 27 Filed by: Sohn Adam Craig
-
Form 3 Z Squared Inc. For: Apr 24 Filed by: Sohn Adam Craig
-
Form 3 ARM HOLDINGS PLC /UK For: Mar 18 Filed by: SOHN YOUNG
-
PharmaResearch gets FDA clearance for cancer drug trial
-
TON Strategy seeks new CEO as Kapustina transitions out
-
Form 13F-HR B. Metzler seel. Sohn & For: Dec 31
-
Form 4 Maze Therapeutics, Inc. For: Jan 06 Filed by: Sohn Catherine A.
-
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
-
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
-
Form 4 Altimmune, Inc. For: Jan 05 Filed by: Sohn Catherine A.
-
Form 144 Nixxy, Inc. Filed by: Sohn Evan
-
Gotham City takes short position in Iron Mountain shares
-
Form 13F-HR B. Metzler seel. Sohn & For: Sep 30
-
HOPE Therapeutics launches one-day depression treatment in Florida
-
Form 4 Altimmune, Inc. For: Sep 25 Filed by: Sohn Catherine A.
-
Form 4 Maze Therapeutics, Inc. For: Sep 22 Filed by: Sohn Catherine A.
-
Form N-PX B. Metzler seel. Sohn & For: Jun 30
-
Form 4 Verb Technology Company, For: Aug 07 Filed by: Sohn Evan
-
Form 3 Verb Technology Company, For: Aug 07 Filed by: Sohn Evan
-
Form 13F-HR B. Metzler seel. Sohn & For: Jun 30
-
Form 4 OP Bancorp For: Jun 26 Filed by: Sohn Myung Shin
-
Form 4 CADENCE DESIGN SYSTEMS For: Jun 12 Filed by: SOHN YOUNG
-
Form 4 OP Bancorp For: May 30 Filed by: Sohn Myung Shin
-
Form 13F-HR B. Metzler seel. Sohn & For: Mar 31
-
Main Street Capital (MAIN) Said to Mentioned as Short at Jehoshaphat Research
-
Form 4 CADENCE DESIGN SYSTEMS For: May 08 Filed by: SOHN YOUNG
-
Nixxy (NIXX) Appoints Mike Schmidt as CEO
-
Form 4 Nixxy, Inc. For: Apr 23 Filed by: Sohn Evan
-
Tucows (TCX) Announces Director Nominations and Honors Departing Board Members
-
Form 4 Altimmune, Inc. For: Mar 17 Filed by: Sohn Catherine A.
-
Nixxy's (NIXX) Auralink AI Announces Up to $120 Million AI-Enabled Reciprocal Telecommunications Services Agreement with a Global Technology Provider
-
Form 13F-HR B. Metzler seel. Sohn & For: Dec 31
-
Form 4 Altimmune, Inc. For: Feb 06 Filed by: Sohn Catherine A.
-
Form 3 Maze Therapeutics, Inc. For: Jan 30 Filed by: Sohn Catherine A.
-
Nixxy (NIXX) Appoints Debra Chen Volpone as CEO and Board Member
-
e.l.f. Beauty, Inc. (ELF) Mentioned Cautiously at Muddy Waters
-
Form 13F-HR B. Metzler seel. Sohn & For: Sep 30
-
Form 13F-HR B. Metzler seel. Sohn & For: Sep 30
-
Form 4 Altimmune, Inc. For: Sep 26 Filed by: Sohn Catherine A.
-
Arm Holdings (ARM) Appoints Young Sohn to its Board
-
Form N-PX B. Metzler seel. Sohn & For: Jun 30
-
Form 13F-HR B. Metzler seel. Sohn & For: Jun 30
-
Form 144 Jazz Pharmaceuticals Filed by: Sohn Catherine A.
-
NeuroBo Pharmaceuticals (NRBO) Announces Exclusive License Agreement with MThera Pharma for NB-01
